Trials / Completed
CompletedNCT02663232
Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma
Epidemiological Study of V600 BRAF Mutation in Spanish Patients Diagnosed With Metastatic Melanoma: ABSOLUT-BRAF Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 264 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a national, multicenter, cross-sectional epidemiological study in adult Spanish participants diagnosed with advanced or metastatic melanoma.
Conditions
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2016-01-26
- Last updated
- 2023-07-03
- Results posted
- 2016-04-05
Locations
33 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02663232. Inclusion in this directory is not an endorsement.